Indian scientists have developed a low-cost rotavirus vaccine that could prevent severe infant diarrhea. At $1 per dose, it could save thousands of children’s lives each year in Asia and Africa. At a fraction of...
Swiss pharmaceutical Roche is set to publish clinical study results, after being accused of covering negative outcomes. DW spoke with Michael Doherty, Global Head of Regulatory Affairs at Roche. DW: Roche has decided to open...